Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shafa Yaab Drug is a leading Iranian pharmaceutical company specializing in the import, distribution, and manufacturing of high-tech and life-saving medicines. Founded in 1994, the company has established itself as a critical partner for international pharmaceutical giants, facilitating the availability of advanced therapies in the Iranian market. Their portfolio primarily focuses on oncology, rare diseases, and biotechnology-derived products. In addition to its distribution network, the company has expanded into local manufacturing to ensure the sustainability of the drug supply chain. Shafa Yaab Drug is recognized for its adherence to international quality standards and its role in providing specialized treatments for complex medical conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shafa Yaab Drug.